Global Markets for Artificial Intelligence in Drug Discovery

Global Markets for Artificial Intelligence in Drug Discovery

Report Code: HLC290A

Publish Date: Sep 2023

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for artificial intelligence (AI) in drug discovery is estimated to increase from $1.6 billion in 2023 to $5.7 billion by 2028, at a compound annual growth rate (CAGR) of 29.6% from 2023 through 2028.

Report Includes

  • 49 data tables and 30 additional tables
  • An up-to-date overview and industry analysis of the global markets for artificial intelligence (AI) in drug discovery
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the actual market size and revenue forecast for the AI in drug discovery market, and corresponding market share analysis based on application, therapeutic area, and region
  • In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
  • Understanding of the importance of ESG in the AI in drug discovery market, consumer attitudes, risks and opportunity assessment, and ESG followed practices by top vendor companies
  • Discussion of emerging technologies and new developments in the AI in drug discovery market
  • Identification of the major and emerging players who are considered as leaders in the AI in drug discovery market, as well as technological means these companies are using to exploit their markets and dominate the market in their fields
  • Review of the structure of this industry with respect to company market shares, venture fundings, and recent merger and acquisition (M&A) activities
  • Analysis of their company competitive landscape based on recent developments, key financials and segmental revenues, and operational integration
  • Detailed company profiles of the leading market players, including Atomwise Inc., BenevolentAI, Insilico Medicine, Exscientia plc, Recursion Pharmaceuticals Inc., and Schrödinger

Report Scope

The current report will provide a detailed overview of the AI in the drug discovery market. This report analyzes the market trends associated with AI in drug discovery using data from 2020, estimates from 2022, projections of compound annual growth rates through 2028 (i.e., the forecast period 2023-2028), and information about regional markets of AI in drug discovery. This report will highlight the current and future market potential of AI in drug discovery and provide a detailed analysis of the competitive environment. It will cover regulatory scenarios, drivers, restraints and opportunities as well as market projections for 2028 and the market shares held by key market players.

The scope of the market in this report is segmented into applications, therapeutic areas and region. The applications of AI in drug discovery are further segmented into preclinical testing, target identification, candidate screening and lead optimization, drug repurposing, De novo Drug Design and others. The AI in drug discovery market is segmented by therapeutic area into the following segments: oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, infectious diseases, and others. This report includes a regional market analysis of AI in drug discovery. The market has been segmented by region into various significant geographies: North America, Europe, Asia-Pacific, and the Rest of the World regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China and India will be covered within the chapter focused on regional segmentation. For market estimates, 2022 serves the base year; forecasts are given from 2023-2028.

The regional market analysis of AI in drug discovery is also covered in this report. The market has been segmented into various significant geographies, including North America, Europe, Asia-Pacific, and other world regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India will be covered within the regional segment. For market estimates, data will be provided for 2022 because of the base year, with estimates for 2023 and forecast value for 2028.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $1.3 billion
Market size forecast $5.7 billion
Growth rate CAGR of 29.6% from 2023 to 2028
Units considered $ Millions
Segments covered By Application, Therapeutic Area, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.S., Canada, Germany, the UK, France, Italy, Spain, Japan, China, India, and South Korea
Key Market Drivers
  • Rising Prevalence of Chronic and Infectious Diseases Globally
  • Increasing Adoption of AI in Pharmaceutical Sector
  • Potential of AI in Pharma Sector
Companies studied
ARIA PHARMACEUTICALS INC.ATOMWISE INC.
BENEVOLENTAIEXSCIENTIA
INSILICO MEDICINERECURSION PHARMACEUTICALS
RELAY THERAPEUTICS INC.SCHRODINGER INC.
XTALPI INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? Explore Offers

The global market for AI in drug discovery is estimated at $1.2 million in 2022 and is expected to grow at a CAGR of 29.6% to nearly $5.7 billion by 2028.

The growth of the global market is attributed to factors such as the rising prevalence of chronic & infectious diseases globally, increasing adoption of AI in pharmaceutical sector and potential of AI in medical sector.

The AI in the drug discovery market is segmented based on therapeutic areas, application, and region.

The Candidate Screening & Lead Optimization in drug discovery segment will dominate the market by the end of 2028, but Preclinical Testing in drug discovery will grow in the forecasted period.

North America holds the highest share in the global market.

Key companies in the market include Exscientia, Atomwise, Inc., Schrödinger, BenevolentAI, Insilico Medicine, Recursion Pharmaceuticals, and others.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Artificial Intelligence in Drug Discovery172Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview5Free
Chapter- 4: Market Dynamics38Free
Chapter- 5: Regulatory Landscape and Reimbursement Scenario7Free
Chapter- 6: Impact of COVID-19 on Market4Free
Chapter- 7: Market Breakdown by Application14Free
Chapter- 8: Market Breakdown by Therapeutic Area13Free
Chapter- 9: Market Breakdown by Region16Free
Chapter- 10: ESG Development8Free
Chapter- 11: Emerging Technologies and Developments5Free
Chapter- 12: M&A and Funding Outlook10Free
Chapter- 13: Competitive Landscape4Free
Chapter- 14: Company Profiles34Free
Chapter- 15: Appendix: Acronyms2Free

Related Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Global Edge AI Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - IFT310A

The global market for edge AI was valued at $8.7 billion in 2024 and is estimated to increase from $11.8 billion in 2025 to reach $56.8 billion by 2030, at a compound annual growth rate (CAGR) of 36.9% from 2025 through 2030.

Organ-on-a-Chip: Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO188C

The global Organ-on-a-Chip market is expected to grow from $153.2 million in 2024 and is projected to reach $651.9 million by the end of 2029, at a compound annual growth rate (CAGR) of 33.6% during the forecast period of 2024 to 2029.

2024 AI & IoT Technology Research Review

Published - Mar 2025 | Publisher - Various Analysts | Code - IFT317A

This 2024 Research Review of AI & IoT Technology Market provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 79

  • Summary Table: Global Market for AI in Drug Discovery, by Application, Through 2028
  • Table 1: Global Totals of Angina Pectoris and Stroke Survivors, Through 2030
  • Table 2: Global Incidence and Prevalence of All Stroke Types, 2019
  • Table 3: Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
  • Table 4: Global Diabetes Prevalence, Estimates and Projections, 2019-2045
  • Table 5: Cases of Diabetes Worldwide, by Type, 2019
  • Table 6: Global Prevalence of Diabetes, by Type, Through 2040
  • Table 7: Global Prevalence of Breast Cancer Cases, by Country/Region, Through 2025
  • Table 8: Global Epidemiology of Colorectal Cancer, by Region, Through 2030
  • Table 9: Global Occurrences of Deaths, by Various Cancer Types, Through 2030
  • Table 10: Breakdown of Global Deaths Due to Cancer, by Various Cancer Types, 2021
Sample Report

Recent Reports

Anesthesia and Respiratory Devices: Global Markets

Published - Aug 2025 | Publisher - BCC Publishing | Code - HLC167E

The global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2025 to 2030.

Tissue Engineering and Regeneration: Technologies and Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC101E

The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.

6G in Healthcare: Global Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC306A

This report provides an analysis of the global market trends for 6G in healthcare. It focuses on the significant driving trends and challenges that affect the global market. The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for 6G in healthcare.

Healthcare Innovation in the GCC

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC307A

The report provides an analysis of the healthcare landscape in the Gulf Cooperation Council (GCC) countries. The report estimates the Total Addressable Market (TAM) for the GCC healthcare sector from 2024 to 2030, offering country-specific projections. This analysis provides critical insights into the commercial potential and investment opportunities in the region’s rapidly evolving healthcare ecosystem. The countries included in the analysis are Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Oman, and Bahrain.

Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa

Published - Jun 2025 | Publisher - BCC Publishing | Code - HLC305A

This report presents an in-depth analysis of the MENA beauty and personal care market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, opportunities, and market projections for 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Artificial Intelligence in Drug Discovery
Customize Report Sample Report